US Stock MarketDetailed Quotes
DSNKY Daiichi Sankyo (ADR)
- 32.030
- +1.170+3.79%
15min DelayTrading Apr 26 12:23 ET
61.42BMarket Cap47.66P/E (TTM)
32.230High31.840Low103.32KVolume31.960Open30.860Pre Close3.31MTurnover0.01%Turnover Ratio47.66P/E (Static)1.92BShares37.56652wk High5.63P/B61.42BFloat Cap23.72052wk Low0.14Dividend TTM1.92BShs Float37.566Historical High0.42%Div YieldTTM1.26%Amplitude18.050Historical Low32.014Avg Price1Lot Size
About Daiichi Sankyo (ADR) Company
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Company Profile
SymbolDSNKY
Company NameDaiichi Sankyo (ADR)
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111
Company Executives
- Name
- Position
- Salary
- Sunao Manabe
- Chairman of the Board and Chief Executive Officer
- --
- Masahiko Ohtsuki
- Director, Senior Executive Officer, Chief Information Officer, Global Management Structure and Head, Global DX and Digital Transformation Management Unit
- --
- Hiroyuki Okuzawaa
- Director, President and Chief Operating Officer
- --
- Shoji Hirashima
- Director, Senior Executive Officer and Head, Japan Business Unit
- --
- Takashi Fukuoka
- Director, Senior Executive Officer and Head, Global Corporate Strategy
- --
- Yasuhiro Komatsu
- Independent Director
- --
- Takaaki Nishii
- Independent Director
- --
- Sawako Nohara
- Independent Director
- --
- Kazuaki Kama
- Independent Director
- --
Analysis
Price Target
No Data
Business Data
Revenue by product
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg